Countermeasures and Mechanisms of Drug Resistance in Immunotherapy for Cervical Cancer

VernacularTitle:宫颈癌免疫治疗的耐药机制及应对措施
Author: Junyuan YANG ¹ ; Hongbing CAI
Author Information

1. Department of Gynecology and Oncology, Zhongnan Hospital of Wuhan University, Hubei Medical Oncology Research Center, Hubei Key Laboratory of Tumor Biological Behavior, Wuhan 430071, China
Publication Type:Research Article
Keywords: Cervical cancer; Immunotherapy; Drug resistance; Immune escape; Immune checkpoint inhibitors
From: Cancer Research on Prevention and Treatment 2022;49(9):886-892
CountryChina
Language:Chinese
Abstract: Cervical cancer has become a serious threat to women's health worldwide, advanced cervical cancer has limited treatment options. 5-year survival rate is less than 20%, which is a huge challenge for the gynecologic oncology community. Immunotherapy is one of the important treatment for patients with advanced cervical cancer. including immune checkpoint inhibitors, therapeutic vaccines, and periprocedural T-cell immunotherapy, etc. However, immunotherapy resistance makes some patients non-responsive and ineffective. Therefore, there is an urgent need to study and explore the mechanism of immune resistance to improve drug resistance. The present review summarizes the relevant studies on the mechanism of immune resistance in cervical cancer in recent years, mainly divided into factors such as intrinsic tumor and altered external immune environment, and introduces the countermeasures and progresses proposed for immune resistance.